603259 藥明康德
按盤價 
128.500 +0.070 (+0.055%) | 2026/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 28,897,479 | 38.93% | 45,456,166 | 39,241,431 | 40,340,807 | 39,354,778 | |
| 減：營業總成本 | 16,254,492 | 15.98% | 29,148,155 | 27,342,268 | 28,708,591 | 29,800,811 | |
| 其中:營業成本 | 13,319,000 | 15.27% | 23,801,435 | 22,964,515 | 23,728,800 | 24,677,217 | |
| 財務費用 | 213,258 | 3.42% | 398,191 | (786,684) | (338,119) | (247,968) | |
| 資產減值損失 | (68,369) | -78.73% | (541,556) | (1,236,258) | (156,509) | (175,951) | |
| 公允價值變動收益 | 684,234 | -475.58% | (137,098) | 186,958 | (37,809) | 770,079 | |
| 投資收益 | 227,724 | -93.79% | 8,588,017 | 604,162 | 233,849 | 187,949 | |
| 其中：對聯營企業和合營企業的投資收益 | 147,430 | -38.64% | 452,582 | 245,065 | (67,560) | (46,271) | |
| 營業利潤 | 13,530,328 | 36.24% | 23,930,084 | 11,580,175 | 11,872,286 | 10,652,249 | |
| 利潤總額 | 13,517,559 | 36.44% | 23,906,151 | 11,539,812 | 11,831,991 | 10,618,476 | |
| 減：所得稅費用 | 2,391,225 | 91.75% | 4,573,085 | 1,972,072 | 2,131,731 | 1,715,866 | |
| 淨利潤 | 11,126,334 | 28.47% | 19,333,066 | 9,567,740 | 9,700,260 | 8,902,611 | |
| 減：非控股權益 | 46,160 | -53.59% | 182,483 | 117,431 | 93,511 | 88,898 | |
| 股東淨利潤 | 11,080,174 | 29.43% | 19,150,582 | 9,450,308 | 9,606,749 | 8,813,713 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 3.800 | 26.25% | 6.700 | 3.280 | 3.270 | 3.010 | |
| 每股派息 (元) * | 0.510 | -27.14% | 2.279 | 0.982 | 0.990 | 0.893 | |
| 每股淨資產 (元) * | 27.929 | 33.89% | 26.715 | 20.302 | 18.570 | 15.737 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 03/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
